{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:20:16Z","timestamp":1788254416168,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01960-3","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:21:03Z","timestamp":1788250863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphatidylethanolamine-mediated metabolic membrane remodeling in obesity-associated Alzheimer\u2019s disease: mechanisms, neuroimmune crosstalk, and therapeutic potential"],"prefix":"10.1007","volume":"41","author":[{"given":"Mumtaz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moh","family":"Aijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamamd Anas","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"1960_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/978-3-031-34229-5_14","volume":"33","author":"IO Akefe","year":"2023","unstructured":"Akefe IO, Osborne SL, Matthews B, Wallis TP, Meunier FA (2023) Lipids and Secretory Vesicle Exocytosis. Adv Neurobiol. 33:357\u201397. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37615874\/. Cited 2026 May 18","journal-title":"Adv Neurobiol."},{"issue":"9","key":"1960_CR2","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jmb.2019.03.006","volume":"431","author":"BI Aldana","year":"2019","unstructured":"Aldana BI (2019) Microglia-Specific Metabolic Changes in Neurodegeneration. J Mol Biol. 431(9):1830\u201342. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S002228361930124X. Cited 2026 May 18","journal-title":"J Mol Biol."},{"issue":"1","key":"1960_CR3","first-page":"25741","volume":"14","author":"KI Avgerinos","year":"2024","unstructured":"Avgerinos KI, Manolopoulos A, Ferrucci L, Kapogiannis D (2024) Critical assessment of anti-amyloid-\u03b2 monoclonal antibodies effects in Alzheimer\u2019s disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness. Sci Reports 14(1):25741. Available from: https:\/\/www.nature.com\/articles\/s41598-024-75204-8. Cited 2026 May 18","journal-title":"Sci Reports"},{"issue":"1","key":"1960_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s10571-026-01691-0","volume":"46","author":"DH Bach","year":"2026","unstructured":"Bach DH, Nguyen TL (2026) Immunometabolism Reframes Alzheimer\u2019s Disease: From Systemic Dysmetabolism to Glial Rewiring. Cell Mol Neurobiol 46(1):56. Available from: https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01691-0. Cited 2026 May 17","journal-title":"Cell Mol Neurobiol"},{"issue":"4","key":"1960_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","volume":"20","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Rawal R, Sharma P, Singh T, Singh M, Singh V (2022) Mitochondrial Dysfunction in Alzheimer\u2019s Disease: Opportunities for Drug Development. Curr Neuropharmacol. 20(4):675. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9878959\/. Cited 2026 May 18","journal-title":"Curr Neuropharmacol."},{"issue":"4","key":"1960_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3233\/JAD-230061","volume":"93","author":"JK Blusztajn","year":"2023","unstructured":"Blusztajn JK, Slack BE (2023) Accelerated breakdown of phosphatidylcholine and phosphatidylethanolamine is a predominant brain metabolic defect in Alzheimer\u2019s disease. J Alzheimers Dis. 93(4):1285. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10885637\/. Cited 2026 May 21","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"1960_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13024-025-00876-3","volume":"20","author":"T Burg","year":"2025","unstructured":"Burg T, Van Den Bosch L (2025) Glycerophospholipids in ALS: insights into disease mechanisms and clinical implication. Mol Neurodegener 20(1):85. Available from: https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00876-3. Cited 2026 May 17","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1960_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12979-024-00496-3","volume":"22","author":"MJ Butler","year":"2025","unstructured":"Butler MJ, Muscat SM, Caetano-Silva ME, Shrestha A, Olmo BMG, Mackey-Alfonso SE et al (2025) Obesity-associated memory impairment and neuroinflammation precede widespread peripheral perturbations in aged rats. Immun Ageing. 22(1):2 Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11697663\/. Cited 2026 May 17","journal-title":"Immun Ageing."},{"key":"1960_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","volume":"321","author":"E Calzada","year":"2016","unstructured":"Calzada E, Onguka O, Claypool SM (2016) Phosphatidylethanolamine Metabolism in Health and Disease. Int Rev Cell Mol Biol. 321:29\u201388. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26811286\/. Cited 2026 May 18","journal-title":"Int Rev Cell Mol Biol."},{"key":"1960_CR10","doi-asserted-by":"publisher","first-page":"1430465","DOI":"10.3389\/fnins.2024.1430465","volume":"18","author":"Y Cao","year":"2024","unstructured":"Cao Y, Zhao LW, Chen ZX, Li SH (2024) New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer\u2019s disease. Front Neurosci. 18:1430465. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11422391\/. Cited 2026 May 18","journal-title":"Front Neurosci."},{"issue":"2","key":"1960_CR11","doi-asserted-by":"publisher","first-page":"166967","DOI":"10.1016\/j.bbadis.2023.166967","volume":"1870","author":"JCS Chaves","year":"2024","unstructured":"Chaves JCS, Dando SJ, White AR, Oikari LE (2024) Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer\u2019s disease and strategies for treatment. Biochim Biophys Acta Mol Basis Dis. 1870(2):166967. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38008230\/. Cited 2026 May 18","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"3","key":"1960_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s42255-026-01477-0","volume":"8","author":"B Chen","year":"2026","unstructured":"Chen B, Rodr\u00edguez-D\u00edaz A, Schneeberger M, Topol E (2026) Obesity as a catalyst for neurodegeneration. Nat Metab 8(3):546\u201358 Available from: https:\/\/www.nature.com\/articles\/s42255-026-01477-0. Cited 2026 May 17","journal-title":"Nat Metab"},{"key":"1960_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-025-00638-8","author":"LYT Cheong","year":"2025","unstructured":"Cheong LYT, Saipuljumri EN, Loi GWZ, Zeng J, Lo CH (2025) Autolysosomal dysfunction in obesity-induced metabolic inflammation and related disorders. Curr Obes Rep. https:\/\/doi.org\/10.1007\/s13679-025-00638-8","journal-title":"Curr Obes Rep"},{"issue":"6","key":"1960_CR14","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3390\/ijms22063054","volume":"22","author":"A D\u2019aloia","year":"2021","unstructured":"D\u2019aloia A, Molteni L, Gullo F, Bresciani E, Artusa V, Rizzi L et al (2021) Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective Effects. Int J Mol Sci. 22(6):3054. Available from: https:\/\/www.mdpi.com\/1422-0067\/22\/6\/3054\/htm. Cited 2026 May 21","journal-title":"Int J Mol Sci."},{"issue":"6","key":"1960_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 25(6):424. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12187608\/. Cited 2026 May 18","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1960_CR16","doi-asserted-by":"crossref","unstructured":"Fadaei R, Bernstein AC, Jenkins AN, Pickens AG, Zarrow JE, Alli-Oluwafuyi AM, et al. N-Aldehyde-Modified Phosphatidylethanolamines generated by lipid peroxidation are robust substrates of N-Acyl Phosphatidylethanolamine Phospholipase D. bioRxiv . 2024.10.30.621135. Available from: https:\/\/www.biorxiv.org\/content\/10.1101\/2024.10.30.621135v1.. Cited 2026 May 21","DOI":"10.1101\/2024.10.30.621135"},{"issue":"1","key":"1960_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s43556-026-00443-2","volume":"7","author":"JQ Feng","year":"2026","unstructured":"Feng JQ, Yang LL, Luo YX, Yao XQ (2026) Alzheimer\u2019s disease: from molecular pathways to therapies. Mol Biomed 7(1):43. Available from: https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00443-2. Cited 2026 May 17","journal-title":"Mol Biomed"},{"issue":"1","key":"1960_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12974-024-03104-9","volume":"21","author":"Z Feng","year":"2024","unstructured":"Feng Z, Fang C, Ma Y, Chang J (2024) Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms. J Neuroinflammation. 21(1):110. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11056074\/. Cited 2026 May 18","journal-title":"J Neuroinflammation."},{"key":"1960_CR19","doi-asserted-by":"publisher","first-page":"101223","DOI":"10.1016\/j.plipres.2023.101223","volume":"90","author":"L Ferr\u00e9-Gonz\u00e1lez","year":"2023","unstructured":"Ferr\u00e9-Gonz\u00e1lez L, Lloret A, Ch\u00e1fer-Peric\u00e1s C (2023) Systematic review of brain and blood lipidomics in Alzheimer\u2019s disease mouse models. Prog Lipid Res. 90:101223. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36871907\/. Cited 2026 May 21","journal-title":"Prog Lipid Res."},{"issue":"1","key":"1960_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-026-02002-x","volume":"18","author":"Y Huh","year":"2026","unstructured":"Huh Y, Nam GE, Han K, Jung JH, Kim BS, Lee D et al (2026) Body mass index levels and changes before and after dementia diagnosis and risk of all-cause mortality: a nationwide cohort study. Alzheimer\u2019s Res Ther 18(1):89. Available from: https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02002-x. Cited 2026 May 18","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"12","key":"1960_CR21","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s12276-025-01611-0","volume":"57","author":"T Jiang","year":"2025","unstructured":"Jiang T, Ma W, Dong W, Zhou H, Mao X (2025) Ferroptosis-associated transcriptional factors in neurological diseases: molecular mechanisms and therapeutic prospects. Exp Mol Med 57(12):2763\u201381. https:\/\/www.nature.com\/articles\/s12276-025-01611-0. Cited 2026 May 21","journal-title":"Exp Mol Med"},{"issue":"6","key":"1960_CR22","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS (2004) Adipose Tissue as an Endocrine Organ. J Clin Endocrinol Metab. 89(6):2548\u201356. Available from: https:\/\/dx.doi.org\/10.1210\/jc.2004-0395. Cited 2026 May 18","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"1960_CR23","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12110","volume":"16","author":"MA Kling","year":"2020","unstructured":"Kling MA, Goodenowe DB, Senanayake V, MahmoudianDehkordi S, Arnold M, Massaro TJ et al (2020) Circulating ethanolamine plasmalogen indices in Alzheimer\u2019s disease: Relation to diagnosis, cognition, and CSF tau. Alzheimer\u2019s Dement. 16(9):1234\u201347. Available from: https:\/\/scholars.uthscsa.edu\/es\/publications\/circulating-ethanolamine-plasmalogen-indices-in-alzheimers-diseas\/. Cited 2026 May 21","journal-title":"Alzheimer\u2019s Dement."},{"issue":"9","key":"1960_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12110","volume":"16","author":"MA Kling","year":"2020","unstructured":"Kling MA, Goodenowe DB, Senanayake V, MahmoudianDehkordi S, Arnold M, Massaro TJ et al (2020) Circulating ethanolamine plasmalogen indices in Alzheimer\u2019s disease: Relation to diagnosis, cognition, and CSF tau. Alzheimers Dement. 16(9):1234\u201347. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32715599\/. Cited 2026 May 21","journal-title":"Alzheimers Dement."},{"key":"1960_CR25","unstructured":"K Jin,\u00a0S Yang, MJ\u00a0Forster. Beyond Amyloid: Rethinking the Foundations of Alzheimer\u2019s Disease Pathogenesis and Therapy. Aging Dis . 2025. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/41452712\/. Cited 2026 May 18"},{"issue":"1","key":"1960_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/lipidology3010006","volume":"3","author":"S Lata","year":"2026","unstructured":"Lata S, Malik S, Mondal S, Bora J, Priya S, Veettil DT et al (2026) Lipids and Their Role in Aging and Neurodegenerative Decline. Lipidol 3(1):6. Available from: https:\/\/www.mdpi.com\/2813-7086\/3\/1\/6\/htm. Cited 2026 May 18","journal-title":"Lipidol"},{"issue":"7","key":"1960_CR27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s42255-024-01079-8","volume":"6","author":"O Le Thuc","year":"2024","unstructured":"Le Thuc O, Garc\u00eda-C\u00e1ceres C (2024) Obesity-induced inflammation: connecting the periphery to the brain. Nat Metab 6(7):1237\u201352. Available from: https:\/\/www.nature.com\/articles\/s42255-024-01079-8. Cited 2026 May 17","journal-title":"Nat Metab"},{"key":"1960_CR28","doi-asserted-by":"publisher","first-page":"1815719","DOI":"10.3389\/fimmu.2026.1815719","volume":"17","author":"T Li","year":"2026","unstructured":"Li T, Guo K, Ma Y, Zhao J, Cao Y, Zhang R et al (2026) Lipid metabolic regulation of neuroinflammation in Alzheimer\u2019s disease. Front Immunol. 17:1815719. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1815719\/full. Cited 2026 May 18","journal-title":"Front Immunol."},{"key":"1960_CR29","doi-asserted-by":"publisher","first-page":"156436","DOI":"10.1016\/j.metabol.2025.156436","volume":"175","author":"J Long","year":"2026","unstructured":"Long J, Liu S, Shi Y, Zhang C, Qin L, Ai Q (2026) Targeting lipid metabolism in neurodegenerative diseases: From experimental to clinical. Metabolism. 175:156436. Available from:  https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0026049525003051?utm_source=chatgpt.com. Cited 2026 May 17","journal-title":"Metabolism."},{"key":"1960_CR30","doi-asserted-by":"publisher","first-page":"1795058","DOI":"10.3389\/fphys.2026.1795058","volume":"17","author":"S Mateus-Gomes","year":"2026","unstructured":"Mateus-Gomes S, Al-Sayyar A, Lobey B, Nadjar A, Rua R, Ahmad R (2026) Metabolic inflammation at the adipose-brain axis. Front Physiol. 17:1795058. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2026.1795058\/full. Cited 2026 May 18","journal-title":"Front Physiol."},{"key":"1960_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.lfs.2017.06.002","volume":"182","author":"JN Mazon","year":"2017","unstructured":"Mazon JN, de Mello AH, Ferreira GK, Rezin GT (2017) The impact of obesity on neurodegenerative diseases. Life Sci. 182:22\u20138. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S002432051730276X. Cited 2026 May 18","journal-title":"Life Sci."},{"issue":"9","key":"1960_CR32","doi-asserted-by":"publisher","first-page":"7745","DOI":"10.3390\/ijms24097745","volume":"24","author":"LYM Michel","year":"2023","unstructured":"Michel LYM (2023) Extracellular Vesicles in Adipose Tissue Communication with the Healthy and Pathological Heart. Int J Mol Sci 24(9):7745. Available from: https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7745\/htm. Cited 2026 May 17","journal-title":"Int J Mol Sci"},{"key":"1960_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2014.04.001","volume":"42","author":"AA Miller","year":"2014","unstructured":"Miller AA, Spencer SJ (2014) Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun 42:10\u201321","journal-title":"Brain Behav Immun"},{"issue":"16","key":"1960_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMra2022774","volume":"383","author":"N Mizushima","year":"2020","unstructured":"Mizushima N, Levine B (2020) Autophagy in Human Diseases. N Engl J Med. 383(16):1564\u201376. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33053285\/. Cited 2026 May 21","journal-title":"N Engl J Med."},{"key":"1960_CR35","doi-asserted-by":"publisher","first-page":"1294420","DOI":"10.3389\/fncel.2023.1294420","volume":"17","author":"A Neto","year":"2023","unstructured":"Neto A, Fernandes A, Barateiro A (2023) The complex relationship between obesity and neurodegenerative diseases: an updated review. Front Cell Neurosci. 17:1294420. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10665538\/. Cited 2026 May 18","journal-title":"Front Cell Neurosci."},{"issue":"1","key":"1960_CR36","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1038\/s41467-024-48734-y","volume":"15","author":"M Osetrova","year":"2024","unstructured":"Osetrova M, Tkachev A, Mair W, GuijarroLarraz P, Efimova O, Kurochkin I et al (2024) Lipidome atlas of the adult human brain. Nat Commun 15(1):4455. Available from: https:\/\/www.nature.com\/articles\/s41467-024-48734-y. Cited 2026 May 18","journal-title":"Nat Commun"},{"key":"1960_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115665240415642251205104453","volume":"26","author":"SK Pandey","year":"2026","unstructured":"Pandey SK, Kulshreshtha A, Mishra A (2026) Phosphatidylethanolamine: Structural Component and Beyond. Curr Mol Med. 26:1\u201311. Available from: https:\/\/www.eurekaselect.com\/article\/152581. Cited 2026 May 18","journal-title":"Curr Mol Med."},{"key":"1960_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0115665240415642251205104453","volume":"26","author":"SK Pandey","year":"2026","unstructured":"Pandey SK, Kulshreshtha A, Mishra A (2026) Phosphatidylethanolamine: Structural Component and Beyond. Curr Mol Med. 26:1\u201311. Available from: https:\/\/www.eurekaselect.com\/article\/152581. Cited 2026 May 21","journal-title":"Curr Mol Med."},{"key":"1960_CR39","doi-asserted-by":"crossref","unstructured":"Pandey SK, Kulshreshtha A, Mishra A. Phosphatidylethanolamine: Structural Component and Beyond. Curr Mol Med . 2026. Available from: https:\/\/cris.bgu.ac.il\/en\/publications\/phosphatidylethanolamine-structural-component-and-beyond-2\/ Cited 2026 May 21","DOI":"10.2174\/0115665240415642251205104453"},{"issue":"6","key":"1960_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/jnnp-2023-332661","volume":"95","author":"V Patel","year":"2024","unstructured":"Patel V, Edison P (2024) Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry. 95(6):581\u20139 Available from: https:\/\/jnnp.bmj.com\/content\/95\/6\/581. Cited 2026 May 17","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"1","key":"1960_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43246-025-00773-8","volume":"6","author":"SD Pritzl","year":"2025","unstructured":"Pritzl SD, Morstein J, Pritzl NA, Lipfert J, Lohm\u00fcller T, Trauner DH (2025) Photoswitchable phospholipids for the optical control of membrane processes, protein function, and drug delivery. Commun Mater 6(1):59. Available from: https:\/\/www.nature.com\/articles\/s43246-025-00773-8. Cited 2026 May 18","journal-title":"Commun Mater"},{"key":"1960_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1550907","author":"M Qatanani","year":"2007","unstructured":"Qatanani M, Lazar MA (2007) Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. https:\/\/doi.org\/10.1101\/gad.1550907","journal-title":"Genes Dev"},{"key":"1960_CR43","doi-asserted-by":"crossref","unstructured":"Rathor P, Tiwari AK, Patel RP, Singh SP, CH R. Brain lipidomics identifies mitochondrial redox dysfunction and metabolic trade-offs associated with Parkinson\u2019s disease-like pathology induced by Nanoplastics exposure. bioRxiv . 2025 2025.11.09.687439.","DOI":"10.1101\/2025.11.09.687439"},{"issue":"25","key":"1960_CR44","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM et al (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update From the GBD 2019 Study. J Am Coll Cardiol. 76(25):2982\u20133021. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33309175\/. Cited 2023 Sep 30","journal-title":"J Am Coll Cardiol."},{"issue":"11","key":"1960_CR45","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41574-024-01008-5","volume":"20","author":"MB Schulze","year":"2024","unstructured":"Schulze MB, Stefan N (2024) Metabolically healthy obesity: from epidemiology\u00a0and mechanisms to clinical implications. Nat Rev Endocrinol 20(11):633\u201346. Available from: https:\/\/www.nature.com\/articles\/s41574-024-01008-5. Cited 2026 May 18","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"1960_CR46","doi-asserted-by":"publisher","first-page":"101468","DOI":"10.1016\/j.tjnut.2026.101468","volume":"156","author":"Z Shi","year":"2026","unstructured":"Shi Z, Hao M, Chen G, Li F, Zhou Y, Zhou JC (2026) Phosphatidylethanolamine: Its Biological Significance and Responses to Nutritional Factors for Neurohealth. J Nutr. 156(5):101468. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0022316626001173?utm_source=chatgpt.com. Cited 2026 May 17","journal-title":"J Nutr."},{"issue":"5","key":"1960_CR47","doi-asserted-by":"publisher","first-page":"101468","DOI":"10.1016\/j.tjnut.2026.101468","volume":"156","author":"Z Shi","year":"2026","unstructured":"Shi Z, Hao M, Chen G, Li F, Zhou Y, Zhou JC (2026) Phosphatidylethanolamine: Its Biological Significance and Responses to Nutritional Factors for Neurohealth. J Nutr. 156(5):101468. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0022316626001173?utm_source=chatgpt.com. Cited 2026 May 18","journal-title":"J Nutr."},{"issue":"5","key":"1960_CR48","doi-asserted-by":"publisher","first-page":"101468","DOI":"10.1016\/j.tjnut.2026.101468","volume":"156","author":"Z Shi","year":"2026","unstructured":"Shi Z, Hao M, Chen G, Li F, Zhou Y, Zhou JC (2026) Phosphatidylethanolamine: Its Biological Significance and Responses to Nutritional Factors for Neurohealth. J Nutr. 156(5):101468. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0022316626001173?utm_source=chatgpt.com. Cited 2026 May 21","journal-title":"J Nutr."},{"issue":"1","key":"1960_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-024-00409-w","volume":"13","author":"N Song","year":"2024","unstructured":"Song N, Mei S, Wang X, Hu G, Lu M (2024) Focusing on mitochondria in the brain: from biology to therapeutics. Transl Neurodegener 13(1):23. Available from: https:\/\/link.springer.com\/article\/10.1186\/s40035-024-00409-w. Cited 2026 May 18","journal-title":"Transl Neurodegener"},{"key":"1960_CR50","doi-asserted-by":"publisher","first-page":"1094273","DOI":"10.3389\/fnut.2022.1094273","volume":"9","author":"M St Germain","year":"2023","unstructured":"St Germain M, Iraji R, Bakovic M (2023) Phosphatidylethanolamine homeostasis under conditions of impaired CDP-ethanolamine pathway or phosphatidylserine decarboxylation. Front Nutr. 9:1094273. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9849821\/. Cited 2026 May 21","journal-title":"Front Nutr."},{"issue":"3","key":"1960_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5580","volume":"56","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wei K, Liao X, Wang J, Gao L, Pang B (2025) Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review). Int J Mol Med. 56(3):1\u201319. Available from: http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2025.5580\/abstract. Cited 2026 May 21","journal-title":"Int J Mol Med."},{"issue":"3","key":"1960_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u201350. Available from: https:\/\/www.nature.com\/articles\/nrneurol.2017.188. Cited 2026 May 18","journal-title":"Nat Rev Neurol"},{"key":"1960_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226073","author":"SM Tokuoka","year":"2019","unstructured":"Tokuoka SM, Kita Y, Shimizu T, Oda Y (2019) Isobaric mass tagging and triple quadrupole mass spectrometry to determine lipid biomarker candidates for Alzheimer\u2019s disease. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0226073","journal-title":"PLoS ONE"},{"issue":"8","key":"1960_CR54","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/cells15080672","volume":"15","author":"RM Uranga","year":"2026","unstructured":"Uranga RM, Allani SK (2026) From Lipids to Mitochondria: Shared Metabolic Alterations in Obesity and Alzheimer\u2019s Disease. Cells. 15(8):672. Available from: https:\/\/www.mdpi.com\/2073-4409\/15\/8\/672\/htm. Cited 2026 May 18","journal-title":"Cells."},{"issue":"4","key":"1960_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41583-025-00908-3","volume":"26","author":"S Vanherle","year":"2025","unstructured":"Vanherle S, Loix M, Miron VE, Hendriks JJA, Bogie JFJ (2025) Lipid metabolism, remodelling and intercellular transfer in the CNS. Nat Rev Neurosci 26(4):214\u201331. Available from:https:\/\/www.nature.com\/articles\/s41583-025-00908-3. Cited 2026 May 17","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"1960_CR56","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/ijms27020958","volume":"27","author":"M Vukovi\u0107","year":"2026","unstructured":"Vukovi\u0107 M, Nosek I, Stojanoska MM, Kozi\u0107 D (2026) Neurometabolic and Neuroinflammatory Consequences of Obesity: Insights into Brain Vulnerability and Imaging-Based Biomarkers. Int J Mol Sci 27(2):958. Available from: https:\/\/www.mdpi.com\/1422-0067\/27\/2\/958\/htm. Cited 2026 May 17","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1960_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13024-025-00857-6","volume":"20","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang L, Qin C (2025) Alzheimer\u2019s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response. Mol Neurodegener. 20(1):67. Available from: https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00857-6. Cited 2026 May 17","journal-title":"Mol Neurodegener."},{"issue":"1","key":"1960_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00857-6","volume":"20","author":"Z Wang","year":"2025","unstructured":"Wang Z, Zhang L, Qin C (2025) Alzheimer\u2019s disease pathogenesis: standing at the crossroad of lipid metabolism and immune response. Mol Neurodegener 20(1):67. Available from: https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00857-6. Cited 2026 May 18","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1960_CR59","doi-asserted-by":"publisher","first-page":"100830","DOI":"10.1016\/j.jbc.2021.100830","volume":"297","author":"CJ White","year":"2021","unstructured":"White CJ, Ellis JM, Wolfgang MJ (2021) The role of ethanolamine phosphate phospholyase in regulation of astrocyte lipid homeostasis. J Biol Chem. 297(1):100830 (https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8233209\/. Cited 2026 May 21","journal-title":"J Biol Chem."},{"key":"1960_CR60","doi-asserted-by":"publisher","first-page":"1772036","DOI":"10.3389\/fneur.2026.1772036","volume":"17","author":"X Xiao","year":"2026","unstructured":"Xiao X, Yan X, Liang C, Yang Y (2026) Metabolic dysfunction and mitochondrial failure in Alzheimer\u2019s disease: integrating pathophysiology, clinical evidence and emerging interventions. Front Neurol. 17:1772036. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12979182\/. Cited 2026 May 18","journal-title":"Front Neurol."},{"issue":"1","key":"1960_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-026-00943-3","volume":"21","author":"L Yang","year":"2026","unstructured":"Yang L, Sheng J, Qi S, Yin Z, Chan M, Cao Y et al (2026) Obesity-driven phosphatidylethanolamine dysregulation impairs neuroimmune crosstalk and accelerates Alzheimer\u2019s pathogenesis. Mol Neurodegener 21(1):25 Available from: https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00943-3. Cited 2026 May 17","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1960_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-026-00943-3","volume":"21","author":"L Yang","year":"2026","unstructured":"Yang L, Sheng J, Qi S, Yin Z, Chan M, Cao Y et al (2026) Obesity-driven phosphatidylethanolamine dysregulation impairs neuroimmune crosstalk and accelerates Alzheimer\u2019s pathogenesis. Mol Neurodegener 21(1):25. Available from: https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00943-3. Cited 2026 May 18","journal-title":"Mol Neurodegener"},{"key":"1960_CR63","doi-asserted-by":"publisher","first-page":"1456948","DOI":"10.3389\/fendo.2024.1456948","volume":"15","author":"J Zeng","year":"2024","unstructured":"Zeng J, Cheong LYT, Lo CH (2024) Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration. Front Endocrinol (Lausanne). 15:1456948. Available from:https:\/\/biorender.com. Cited 2026 May 17","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"1960_CR64","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4103\/NRR.NRR-D-24-01412","volume":"21","author":"T Zhang","year":"2025","unstructured":"Zhang T, Yin Y, Xia X, Que X, Liu X, Zhao G et al (2025) Regulation of synaptic function and lipid metabolism. Neural Regen Res. 21(3):1037. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12296456\/. Cited 2026 May 18","journal-title":"Neural Regen Res."},{"issue":"1","key":"1960_CR65","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-025-00812-5","volume":"20","author":"S Zhang","year":"2025","unstructured":"Zhang S, Gao Y, Zhao Y, Huang TY, Zheng Q, Wang X (2025) Peripheral and central neuroimmune mechanisms in Alzheimer\u2019s disease pathogenesis. Mol Neurodegener. 20(1):22. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11846304\/. Cited 2026 May 18","journal-title":"Mol Neurodegener."},{"issue":"6","key":"1960_CR66","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.4103\/NRR.NRR-D-25-00201","volume":"21","author":"Y Zuo","year":"2026","unstructured":"Zuo Y, Amireddy N, Cai Q (2026) Implications of mitochondrial phosphatidylethanolamine in neuronal health and neurodegeneration. Neural Regen Res. 21(6):2254. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40618265\/. Cited 2026 May 21","journal-title":"Neural Regen Res."},{"issue":"6","key":"1960_CR67","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.4103\/NRR.NRR-D-25-00201","volume":"21","author":"Y Zuo","year":"2025","unstructured":"Zuo Y, Amireddy N, Cai Q (2025) Implications of mitochondrial phosphatidylethanolamine in neuronal health and neurodegeneration. Neural Regen Res. 21(6):2254\u20132265. Available from: https:\/\/journals.lww.com\/nrronline\/fulltext\/2026\/06000\/implications_of_mitochondrial.16.aspx. Cited 2026 May 21","journal-title":"Neural Regen Res."}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01960-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01960-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:02:24Z","timestamp":1788253344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01960-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01960-3","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"10 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors used Grammarly AI-assisted language editing software to improve the grammar, clarity, and readability of the manuscript text.","order":1,"name":"Ethics","label":"Use of AI tools","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"200"}}